FDA Approves Pain Reliever Abstral for Cancer Patients
The FDA has approved the use of Abstral for additional pain relief in cancer patients. The drug is an immediate release medication designed to help individuals already on regular opioid pain treatment.
A Joint Venture
A team of researchers at the University of Missouri have successfully regenerated complete shoulder joint surfaces using a patient’s own cells.